The purposes of the study were to: 1. Determine the level of test anxiety present, as measured by the Test Anxiety Questionnaire (TAQ), prior to treatment. 2. Develop an implosive therapy procedure to reduce test anxiety. 3. Administer implosive therapy to subjects in the experimental treatment group. 4. Determine the post-treatment level of test anxiety in the implosive therapy group, placebo-attention control group, and the no-treatment control group. 5. Determine if there were any significant differences in the test anxiety levels in the three groups on the post-treatment TAQ. 6. Investigate the results of a one month follow-up administration of the TAQ to determine the relative stability of test scores.